Lower Doses of Antibiotics and Shorter Treatment Durations Just As Effective on Children with Pneumonia: Study
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Avelox Lawsuit Filed Over Peripheral Neuropathy Risk September 26, 2014 Irvin Jackson Add Your Comments According to claims raised in a recently filed product liability lawsuit against Bayer and Merck, consumers and the medical community were provided inadequate warnings about the link between Avelox and peripheral neuropathy for years, which allegedly left a Tennessee woman with irreversible and permanent nerve damage. The complaint (PDF) was filed last month by Sherri Kellerman, in the U.S. District Court for the Northern District of California. Kellerman indicates that she developed peripheral neuropathy from side effects of Avelox (moxifloxacin), which is a popular antibiotic that is part of a class of medications known as fluoroquinolones. Other medications in the same class include the blockbuster antibiotics Levaquin and Cipro. Learn More About Antibiotic Aortic Aneurysm Lawsuits Side Effects of Avelox, Levaquin, Cipro and Other Fluoroquinolone Antibiotics May Cause Peripheral Neuropathy. Lawyers Are Reviewing Lawsuits Nationwide. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Antibiotic Aortic Aneurysm Lawsuits Side Effects of Avelox, Levaquin, Cipro and Other Fluoroquinolone Antibiotics May Cause Peripheral Neuropathy. Lawyers Are Reviewing Lawsuits Nationwide. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Fluoroquinolone Antibiotic Failure to Warn The case joins a growing number of antibiotic peripheral neuropathy lawsuits being pursued nationwide, which all involve similar allegations that makers of fluoroquinolones provided false and misleading information about the risk of permanent nerve damage that may result from use of the medications. Peripheral neuropathy involves damage to the nerves, which may impair sensation, movement and other aspects of health. Symptoms may include pain, burning, tingling, numbness, weakness and sensitivity to light touches, temperature and motion in the arms and legs. Until last year, the peripheral neuropathy warnings provided with Avelox suggested that the problems were “rare” and failed to adequately disclose that users may be left with irreversible nerve damage, according to allegations raised by Kellerman. In August 2013, the FDA required new, more stringent warnings about the peripheral neuropathy risk with Avelox, Levaquin, Cipro and other fluoroquinolone antibiotics, indicating problems may last for months or years after an individual stops taking the drug. The new label announced by the FDA required the drug makers to warn patients that if they experience symptoms of peripheral neuropathy, they should contact their doctors and be switched to another antibiotic from a different class of drugs. Avelox Risks Withheld Fluoroquinolones are among the most widely used antibiotics in the United States, with about 23.1 million patients receiving prescriptions for an oral version of the antibiotics in 2011. Since it was introduced in 1999, Avelox has increased in popularity within the class, approaching blockbuster drug status. Kellerman alleges that Bayer and Merck knew or should have known about the Avelox peripheral neuropathy risk for years, indicating that studies have linked fluoroquinolones to a risk of permanent nerve damage for years before the medication was even introduced. A study published last month in the medical journal Neuorology suggested that users of oral fluoroquinolones may face double the risk of developing peripheral neuropathy. Researchers found that current users of Avelox and other similar antibiotics faced an 83% increased risk of suffering nerve damage, and new users faced more than double the risk of peripheral neuropathy compared to those not taking the drugs. “Defendants failed to appropriately and adequately inform and warn Plaintiff and Plaintiff’s prescribing physicians of the serious and dangerous risks associated with the use of Avelox concerning peripheral neuropathy, as well as other severe and personal injuries, which are permanent and/or long-lasting in nature, cause significant physical pain and mental anguish, diminished enjoyment of life, and the need for medical treatment, monitoring and/or medications,” according to Kellerman’s complaint. The Avelox lawsuit pursues claims for strict liability, failure to warn, negligence, breach of warranty, fraud, negligent misrepresentation and fraudulent concealment. It comes amid a growing number of similar Levaquin lawsuits and Cipro lawsuits being pursued on behalf of former users of those related antibiotics, which have also been linked to a risk of peripheral neuropathy. Tags: Antibiotics, Avelox, Bayer, Cipro, Levaquin, Merck, Nerve Damage Image Credit: | More Antibiotic Lawsuit Stories New Antiseptic Treatment Could Reduce Antibiotic Use For UTIs: Study March 24, 2022 Lower Doses of Antibiotics and Shorter Treatment Durations Just As Effective on Children with Pneumonia: Study November 30, 2021 Levaquin, Similar Antibiotics May Increase Risk of Cardiac Arrest in Hemodialysis Patients: Study October 26, 2021 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: today) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025) BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: yesterday) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025) Lawyers Selected 32 Hair Relaxer Lawsuits for Bellwether Discovery in MDL (Posted: 2 days ago) Hair relaxer lawsuit plaintiffs and defendants have selected 32 claims to be prepared for early test trials, focusing on ovarian, uterine and endometrial cancer injuries. MORE ABOUT: HAIR RELAXER LAWSUITFormaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (04/29/2025)Hair Relaxer Lawyers To Meet With MDL Judge Amid “Contentious” Disputes Over Bellwether Discovery Plans (04/23/2025)
Lower Doses of Antibiotics and Shorter Treatment Durations Just As Effective on Children with Pneumonia: Study November 30, 2021
Levaquin, Similar Antibiotics May Increase Risk of Cardiac Arrest in Hemodialysis Patients: Study October 26, 2021
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: today) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)
BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: yesterday) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)
Lawyers Selected 32 Hair Relaxer Lawsuits for Bellwether Discovery in MDL (Posted: 2 days ago) Hair relaxer lawsuit plaintiffs and defendants have selected 32 claims to be prepared for early test trials, focusing on ovarian, uterine and endometrial cancer injuries. MORE ABOUT: HAIR RELAXER LAWSUITFormaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (04/29/2025)Hair Relaxer Lawyers To Meet With MDL Judge Amid “Contentious” Disputes Over Bellwether Discovery Plans (04/23/2025)